Membio

10:15 AM - 10:30 AM (EDT), Wednesday, October 23, 2019 ・ 2nd Floor
Membio is on a mission to eliminate the worldwide shortage of blood by manufacturing it outside the body. Using “bleeding edge” technologies we can make an unlimited supply of fully functional and universally accepted red blood cells. All pun’s aside, we are able to make this work by removing the need for a donor by using an “immortalized” cell line which can replicate indefinitely before transforming in a red blood cell. By combining these immortalized cells with Membio’s cell therapy manufacturing technology enables us to unlock cost-effectively production of red blood cells on an industrial scale.
Company Type:
Company Website:
Company HQ State:
Ontario
Company HQ Country:
Canada
Year Founded:
2018
Main Therapeutic Focus:
Lead Product in Development:
cRBC
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided